CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
DMPA immediately postpartum +1 moredrug
Likely dose
DMPA immediately postpartum 150mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02144259
NCT02144259N/ACompleted
CompareCT.gov

The Impact of Contraception on Postpartum Weight Loss: a Prospective Study

University of Pennsylvania·interventional·Posted May 21, 2014·Updated Feb 17, 2017

In Brief

A clinical study evaluating DMPA immediately postpartum and Implanon immediately postpartum for Weight. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWeight
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 21, 2014
Enrollment StartApr 1, 2011
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.1 years ago

Interventions

DMPA immediately postpartumdrug

DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.

Implanon immediately postpartumdrug

Implanon ® is a subdermal implant that contains 68mg of etonogestrel.